These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 1978753
1. CSF neuropeptide Y in alcoholics and normal controls. Roy A, Berrettini W, DeJong J, Adinoff B, Ravitz B, Linnoila M. Psychiatry Res; 1990 Sep; 33(3):215-9. PubMed ID: 1978753 [Abstract] [Full Text] [Related]
2. Cerebrospinal fluid levels of somatostatin, corticotropin-releasing hormone and corticotropin in alcoholism. Roy A, DeJong J, Gold P, Rubinow D, Adinoff B, Ravitz B, Waxman R, Linnoila M. Acta Psychiatr Scand; 1990 Jul; 82(1):44-8. PubMed ID: 1975969 [Abstract] [Full Text] [Related]
3. Shunt related changes in somatostatin, neuropeptide Y, and corticotropin releasing factor concentrations in patients with normal pressure hydrocephalus. Poca MA, Mataró M, Sahuquillo J, Catalán R, Ibañez J, Galard R. J Neurol Neurosurg Psychiatry; 2001 Mar; 70(3):298-304. PubMed ID: 11181849 [Abstract] [Full Text] [Related]
4. Concentrations of corticotropin-releasing hormone, norepinephrine, MHPG, 5-hydroxyindoleacetic acid, and tryptophan in the cerebrospinal fluid of alcoholic patients: serial sampling studies. Geracioti TD, Loosen PT, Ebert MH, Ekhator NN, Burns D, Nicholson WE, Orth DN. Neuroendocrinology; 1994 Dec; 60(6):635-42. PubMed ID: 7535389 [Abstract] [Full Text] [Related]
5. CSF corticotropin releasing hormone, somatostatin, and thyrotropin releasing hormone in schizophrenia. Banki CM, Karmacsi L, Bissette G, Nemeroff CB. Psychiatry Res; 1992 Jul; 43(1):13-21. PubMed ID: 1359593 [Abstract] [Full Text] [Related]
6. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment. Heuser I, Bissette G, Dettling M, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Nemeroff CB, Holsboer F. Depress Anxiety; 1998 Jul; 8(2):71-9. PubMed ID: 9784981 [Abstract] [Full Text] [Related]
7. CSF diazepam-binding inhibitor in alcoholics and normal controls. Roy A, DeJong J, Adinoff B, Barbaccia M, Costa E, Guidotti A, Linnoila M. Psychiatry Res; 1990 Mar; 31(3):261-6. PubMed ID: 2333358 [Abstract] [Full Text] [Related]
8. Lumbar cerebrospinal fluid concentrations of somatostatin and neuropeptide Y in multiple sclerosis. Vécsei L, Csala B, Widerlöv E, Ekman R, Czopf J, Pàlffy G. Brain Res Bull; 1990 Sep; 25(3):411-3. PubMed ID: 1981332 [Abstract] [Full Text] [Related]
9. Hypothalamic-pituitary-adrenal axis functioning and cerebrospinal fluid corticotropin releasing hormone and corticotropin levels in alcoholics after recent and long-term abstinence. Adinoff B, Martin PR, Bone GH, Eckardt MJ, Roehrich L, George DT, Moss HB, Eskay R, Linnoila M, Gold PW. Arch Gen Psychiatry; 1990 Apr; 47(4):325-30. PubMed ID: 2157379 [Abstract] [Full Text] [Related]
10. The hypothalamic-pituitary-adrenal axis in the neuroendocrine regulation of food intake and obesity: the role of corticotropin releasing hormone. Mastorakos G, Zapanti E. Nutr Neurosci; 2004 Apr; 7(5-6):271-80. PubMed ID: 15682923 [Abstract] [Full Text] [Related]
11. Cerebrospinal fluid thyrotropin-releasing hormone concentrations in alcoholics and normal controls. Roy A, Bissette G, Nemeroff CB, DeJong J, Ravitz B, Adinoff B, Linnoila M. Biol Psychiatry; 1990 Nov 01; 28(9):767-72. PubMed ID: 1701664 [Abstract] [Full Text] [Related]
12. Neuropeptides in relation to suicidal behavior in depression. Roy A. Neuropsychobiology; 1993 Nov 01; 28(4):184-6. PubMed ID: 7903797 [Abstract] [Full Text] [Related]
13. Negative correlation between neuropeptide Y profile in the cerebrospinal fluid and growth hormone pulses in the peripheral circulation in goats. Yonezawa T, Mogi K, Li JY, Sako R, Manabe N, Yamanouchi K, Nishihara M. Neuroendocrinology; 2010 Nov 01; 91(4):308-17. PubMed ID: 20453462 [Abstract] [Full Text] [Related]
14. Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram. Nikisch G, Agren H, Eap CB, Czernik A, Baumann P, Mathé AA. Int J Neuropsychopharmacol; 2005 Sep 01; 8(3):403-10. PubMed ID: 15784158 [Abstract] [Full Text] [Related]
15. Effects of estrogen on growth hormone pulsatility in peripheral blood and neuropeptide profiles in the cerebrospinal fluid of goats. Yonezawa T, Mogi K, Li JY, Sako R, Manabe N, Yamanouchi K, Nishihara M. J Reprod Dev; 2011 Apr 01; 57(2):280-7. PubMed ID: 21242654 [Abstract] [Full Text] [Related]
16. Noradrenaline, but not neuropeptide Y, is elevated in cerebrospinal fluid from the third cerebral ventricle following audiovisual stress in gonadectomised rams and ewes. Turner AI, Rivalland ET, Clarke IJ, Lambert GW, Morris MJ, Tilbrook AJ. Neuroendocrinology; 2002 Dec 01; 76(6):373-80. PubMed ID: 12566945 [Abstract] [Full Text] [Related]
17. Cerebrospinal fluid and plasma concentrations of SRIH, beta-endorphin, CRH, NPY and GHRH in obese and normal weight subjects. Brunani A, Invitti C, Dubini A, Piccoletti R, Bendinelli P, Maroni P, Pezzoli G, Ramella G, Calogero A, Cavagnini F. Int J Obes Relat Metab Disord; 1995 Jan 01; 19(1):17-21. PubMed ID: 7719386 [Abstract] [Full Text] [Related]
18. CSF somatostatin in anorexia nervosa and bulimia: relationship to the hypothalamic pituitary-adrenal cortical axis. Kaye WH, Rubinow D, Gwirtsman HE, George DT, Jimerson DC, Gold PW. Psychoneuroendocrinology; 1988 Jan 01; 13(3):265-72. PubMed ID: 2900533 [Abstract] [Full Text] [Related]
19. Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia. Minthon L, Edvinsson L, Gustafson L. Dement Geriatr Cogn Disord; 1997 Jan 01; 8(4):232-9. PubMed ID: 9213068 [Abstract] [Full Text] [Related]
20. Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence. Adinoff B, Anton R, Linnoila M, Guidotti A, Nemeroff CB, Bissette G. Neuropsychopharmacology; 1996 Sep 01; 15(3):288-95. PubMed ID: 8873112 [Abstract] [Full Text] [Related] Page: [Next] [New Search]